Collaborate With Us
Tell us about your idea, technology or innovation and how we can work together to bring it to life.
Lilly is in the early stages of a growth period catalyzed by recently launched products. Our pipeline’s potential remains strong, with new medicines in development to treat a range of diseases. Here are two things we talked about at the 2018 J.P. Morgan Healthcare Conference and will continue to speak to this year:
Launching With Excellence
This year holds much promise for partnerships, and thus the future of our pipeline. And this goal remains: getting high-quality medicines to patients as fast as we can.